| 1. |
Zutt R, van Egmond ME, Elting JW, et al. A novel diagnostic approach to patients with myoclonus. Nat Rev Neurol, 2015, 11(12): 687-697.
|
| 2. |
Jiménez-Jiménez FJ, Puertas I, de Toledo-Heras M. Drug-induced myoclonus: frequency, mechanisms and management. CNS Drugs, 2004, 18(2): 93-104.
|
| 3. |
Janssen S, Bloem BR, van de Warrenburg BP. The clinical heterogeneity of drug-induced myoclonus: an illustrated review. J Neurol, 2017, 264(8): 1559-1566.
|
| 4. |
Patel A, Mittal S, Manchanda S, et al. Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Ann Pharmacother, 2011, 45(1): e7.
|
| 5. |
Erdoes G, Basciani RM, Eberle B. Etomidate-a review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol Scand, 2014, 58(4): 380-389.
|
| 6. |
Valk BI, Struys MMRF. Etomidate and its analogs: a review of pharmacokinetics and pharmacodynamics. Clin Pharmacokinet, 2021, 60(10): 1253-1269.
|
| 7. |
Dürr A, Tassin J, Vidailhet M, et al. D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann Neurol, 2000, 48(1): 127-128.
|
| 8. |
Wang J, Li QB, Wu YY, et al. Efficacy and safety of opioids for the prevention of etomidate-induced myoclonus: a meta-analysis. Am J Ther, 2018, 25(5): e517-e523.
|
| 9. |
Tam MK, Irwin MG, Tse ML, et al. Prolonged myoclonus after a single bolus dose of propofol. Anaesthesia, 2009, 64(11): 1254-1257.
|
| 10. |
Schneider R, Reebye U, Choi C, et al. Seizure-like activity and prolonged central nervous system side effects after intravenous sedation. J Oral Maxillofac Surg, 2008, 66(6): 1277-1282.
|
| 11. |
Walder B, Tramèr MR, Seeck M. Seizure-like phenomena and propofol: a systematic review. Neurology, 2002, 58(9): 1327-1332.
|
| 12. |
Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med, 2008, 34(4): 714-719.
|
| 13. |
Doenicke AW, Roizen MF, Kugler J, et al. Reducing myoclonus after etomidate. Anesthesiology, 1999, 90(1): 113-119.
|
| 14. |
Sedighinejad A, Naderi Nabi B, Haghighi M, et al. Comparison of the effects of low-dose midazolam, magnesium sulfate, remifentanil and low-dose etomidate on prevention of etomidate-induced myoclonus in orthopedic surgeries. Anesth Pain Med, 2016, 6(2): e35333.
|
| 15. |
Hua J, Miao S, Shi M, et al. Effect of butorphanol on etomidate-induced myoclonus: a systematic review and meta-analysis. Drug Des Devel Ther, 2019, 13: 1213-1220.
|
1/5
WeChat